Advaxis Reports Third Quarter Ended July 31, 2022 Financial Results and Provides a Business Update

Stock Information for Advaxis Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Advaxis Inc.

Advaxis and Ayala Pharmaceuticals Complete Merger
Advaxis Updates on the Phase 1 Clinical Trial of ADXS-504 for the Treatment of Early Prostate Cancer
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Advaxis, Inc. (ADXS)
Ayala Pharmaceuticals and Advaxis Enter into Merger Agreement
Advaxis and Ayala Pharmaceuticals Enter into Merger Agreement
Advaxis Updates on the Phase 1 Clinical Trial of ADXS-504 for the Treatment of Early Prostate Cancer
Advaxis Reports Second Quarter Ended April 30, 2022 Financial Results and Provides a Business Update
Advaxis, Inc. Announces 1-for-80 Reverse Stock Split

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.